查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
助眠器：技術和全球市場
市場調查報告書
商品編碼
1225598

助眠器：技術和全球市場

Sleep Aids: Technologies and Global Markets
出版日期: | 出版商: BCC Research | 英文 152 Pages | 訂單完成後即時交付

價格

全球助眠市場規模預計將從 2022 年的 896 億美元增長到 2027 年的 1253 億美元，在 2022-2027 年的預測期內以 6.9% 的複合年增長率增長。

北美地區預計將從 2022 年的 300 億美元增至 2027 年的 421 億美元，同期復合年增長率為 7.0%。 亞太地區也預計在 2027 年達到 368 億美元，高於 2022 年的 245 億美元，同期復合年增長率為 8.4%。

在本報告中，我們研究了全球助眠器市場，並提供了市場概況、對市場增長、轉型和市場規模預測的各種影響因素的分析，每個細分市場和地區的詳細分析、競爭環境、主要收集公司配置文件。

內容

第一章介紹

第 2 章要點摘要

第三章市場與技術背景

  • 概覽
  • 需要睡覺
  • 人工智能在助眠方面的作用
  • 正常睡眠生理學
  • NREM 和 REM 睡眠的周期
  • 4 個非快速眼動睡眠階段
  • 睡眠期間的生理學
  • 新的推薦睡眠時間
  • 各種安眠藥的作用機制
  • 服用安眠藥的注意事項
  • 無需處方藥即可治療失眠
  • 目前的研究重點是睡眠
  • NIH 資助睡眠研究
  • 波特的五力分析

第 4 章 COVID-19 和俄烏戰爭的市場影響

  • 概覽
  • COVID-19 對助眠劑的影響
  • COVID-19 對睡眠的影響
  • COVID-19 的社會影響
  • 對保險公司的影響
  • 對醫療技術評估的影響
  • COVID-19 及其後果對市場的影響
  • 俄烏戰爭對市場的影響

第 5 章市場動態

  • 概覽
  • 市場驅動因素
  • 市場製約因素
  • 市場機會

第 6 章按產品類型劃分的市場細分

  • 概覽
    • 床墊/枕頭
    • 睡眠呼吸暫停設備
    • 藥物
    • 睡眠實驗室
    • 家庭睡眠測試 (HST)

第 7 章市場細分：按睡眠障礙分類

  • 概覽
  • 睡眠障礙的分類
  • 多導睡眠圖測試
  • 多次睡眠潛伏期測試
  • 喚醒維持測試
  • 活動測試
  • 全球助眠市場：按睡眠障礙分類
    • 失眠
    • 睡眠呼吸暫停
    • 不寧腿綜合症 (RLS)
    • 其他

第 8 章市場細分：按地區

  • 概覽
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第9章競爭格局

  • 工業場景

第十章公司簡介

  • ACTIGRAPH LLC
  • ADVANCED BRAIN MONITORING INC.
  • AMBULATORY MONITORING INC.
  • APNEA SCIENCES CORP.
  • BLAIREX LABORATORIES INC.
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRAEBON MEDICAL CORP.
  • CADWELL LABORATORIES INC.
  • CAMNTECH LTD.
  • CIRCADIANCE LLC
  • CLEVELAND MEDICAL DEVICES INC.
  • DRIVE DEVILBISS HEALTHCARE
  • FISHER & PAYKEL HEALTHCARE CORP., LTD.
  • GLIDEWELL
  • HANS RUDOLPH INC.
  • MODERN DENTAL LABORATORY USA
  • NIHON KOHDEN AMERICA INC.
  • PFIZER INC.
  • RESMED INC.

第 11 章附錄：縮略詞列表

Product Code: HLC081E

Highlights:

The global market for sleep aids is estimated to increase from $89.6 billion in 2022 to reach $125.3 billion by 2027, at a compound annual growth rate (CAGR) of 6.9% from 2022 through 2027.

North American market for sleep aids is estimated to increase from $30.0 billion in 2022 to reach $42.1 billion by 2027, at a CAGR of 7.0% from 2022 through 2027.

Asia-Pacific market for sleep aids is estimated to increase from $24.5 billion in 2022 to reach $36.8 billion by 2027, at a CAGR of 8.4% from 2022 through 2027.

Report Scope:

This report offers a detailed picture of the sleep aids market.

This report highlights the current and future market potential for sleep aids and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2027, as well as key market players.

This report details market shares for sleep aids based on product, sleep disorder and geography. Based on product, the market is segmented into mattresses and pillows, sleep apnea devices, medications, sleep laboratories, and home sleep tests. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS) and others.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2021 as the base year, with forecasts for 2021 through 2027. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 33 data tables and 37 additional tables
  • A comprehensive overview and an up-to-date analysis of the global market for sleep aids
  • Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the upcoming market potential for sleep aids, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of the actual market size and revenue forecast for global sleep aids market in USD million values, and corresponding market share analysis based on product type, sleep disorder type, and region
  • Updated information on market drivers and opportunities for sleep aids industry, key shifts and regulations, technology specific challenges, and other demographic factors affecting the sleep aids market demand over the forecast period (2022-2027)
  • Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China, India, South Korea, and other emerging countries
  • A comparative study and Porter's Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep aids market
  • Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global market for sleep aids
  • Coverage of the technological, economic, and business considerations of the sleep aids market, with global market data analyses and growth forecasts through 2027
  • Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
  • Detailed company profiles of the leading market players, including Advanced Brain Monitoring Inc., Ambulatory Monitoring Inc. (AMI), Boehringer Ingelheim GmbH, Fisher & Paykel Healthcare Ltd., Pfizer Inc., and ResMed Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Introduction
  • 1.2 Study Goals and Objectives
  • 1.3 Reasons for Doing This Study
  • 1.4 Scope of Report
  • 1.5 What's New in This Update?
  • 1.6 Information Sources
  • 1.7 Research Methodology
  • 1.8 Geographic Breakdown
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • 3.1 Overview
  • 3.2 Necessity of Sleep
  • 3.3 Role of AI in Sleep Aids
  • 3.4 Physiology of Normal Sleep
  • 3.5 NREM and REM Sleep Cycles
  • 3.6 Four Stages of NREM Sleep
    • 3.6.1 Stage 1 Sleep
    • 3.6.2 Stage 2 Sleep
    • 3.6.3 Stages 3 and 4 Sleep
    • 3.6.4 REM Sleep
  • 3.7 Physiology During Sleep
  • 3.8 Newly Recommended Sleep Durations
  • 3.9 Mechanism of Action for Different Sleep Drugs
  • 3.10 Precautions for Using Sleeping Pills
  • 3.11 Treating Insomnia without Prescription Drugs
    • 3.11.1 OTC Sleeping Pills
    • 3.11.2 OTC Natural Sleep Aids
  • 3.12 Current Research Focused on Sleep
  • 3.13 NIH Funding for Research on Sleep
  • 3.14 Porter's Five Forces Analysis of the Market for Sleep Aids
    • 3.14.1 Bargaining Power of Suppliers
    • 3.14.2 Bargaining Power of Buyers
    • 3.14.3 Threat of New Entrants
    • 3.14.4 Threat of Substitutes
    • 3.14.5 Degree of Competition

Chapter 4 Impact of COVID-19 and Russia-Ukraine War on the Market

  • 4.1 Overview
  • 4.2 Impact of COVID-19 on Sleep Aids
    • 4.2.1 Stress
    • 4.2.2 Anxiety and Depression
    • 4.2.3 Social Isolation
  • 4.3 Impact of COVID-19 on Sleep
  • 4.4 Social Impact of COVID-19
  • 4.5 Impact on Insurance Providers
  • 4.6 Impact on Health Technology Assement
  • 4.7 Impact of COVID-19 and Its Aftermath on the Market for Sleep Aids
  • 4.8 Impact of Russia-Ukraine War on the Market for Sleep Aids

Chapter 5 Market Dynamics

  • 5.1 Overview
  • 5.2 Market Drivers
    • 5.2.1 Growing Number of Insomnia Disorders
    • 5.2.2 Increasing Prevalence of Obstructive Sleep Apnea (OSA)
    • 5.2.3 Increasing Demand for Medication including Herbal Medicines Due to Unhealthy Lifestyles
    • 5.2.4 Increase in Geriatric Population Across the World
  • 5.3 Market Restraints
    • 5.3.1 Side Effects of Medication
  • 5.4 Market Opportunities
    • 5.4.1 Growing Number of Sleep Aid Product Innovations
    • 5.4.2 Opportunities in the Emerging Nations

Chapter 6 Market Breakdown by Product Type

  • 6.1 Overview
    • 6.1.1 Mattresses and Pillows
    • 6.1.2 Sleep Apnea Devices
    • 6.1.3 Medications
    • 6.1.4 Sleep Laboratories
    • 6.1.5 Home Sleep Testing (HST)

Chapter 7 Market Breakdown by Sleep Disorder

  • 7.1 Overview
  • 7.2 Classification of Sleep Disorders
  • 7.3 Polysomnogram Tests
    • 7.3.1 Disorders Diagnosed by PSG
    • 7.3.2 Equipment Used for the Diagnosis of PSG
    • 7.3.3 Results of a PSG
  • 7.4 Multiple Sleep Latency Test
  • 7.5 Maintenance of Wakefulness Test
  • 7.6 Actigraphy Tests
  • 7.7 Global Market for Sleep Aids, by Sleep Disorder
    • 7.7.1 Insomnia
    • 7.7.2 Sleep Apnea
    • 7.7.3 Restless Legs Syndrome (RLS)
    • 7.7.4 Others

Chapter 8 Market Breakdown by Region

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 United States
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 United Kingdom
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia-Pacific
  • 8.5 Latin America
  • 8.6 Middle East and Africa

Chapter 9 Competitive Landscape

  • 9.1 Industry Scenario
    • 9.1.1 Opportunity: Emerging Markets

Chapter 10 Company Profiles

  • ACTIGRAPH LLC
  • ADVANCED BRAIN MONITORING INC.
  • AMBULATORY MONITORING INC.
  • APNEA SCIENCES CORP.
  • BLAIREX LABORATORIES INC.
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRAEBON MEDICAL CORP.
  • CADWELL LABORATORIES INC.
  • CAMNTECH LTD.
  • CIRCADIANCE LLC
  • CLEVELAND MEDICAL DEVICES INC.
  • DRIVE DEVILBISS HEALTHCARE
  • FISHER & PAYKEL HEALTHCARE CORP., LTD.
  • GLIDEWELL
  • HANS RUDOLPH INC.
  • MODERN DENTAL LABORATORY USA
  • NIHON KOHDEN AMERICA INC.
  • PFIZER INC.
  • RESMED INC.

Chapter 11 Appendix: List of Acronyms

List of Tables

  • Summary Table : Global Market for Sleep Aids, by Region, Through 2027
  • Table 1 : Amount of Sleep Humans Need
  • Table 2 : Physiological Changes During NREM and REM Sleep
  • Table 3 : Selected Sleep Drugs, Mechanism of Action, Duration of Effect and Dependence Risk
  • Table 4 : NICHD-Funded Research on Sleep
  • Table 5 : Porter's Five Forces Analysis: Global Sleep Aids Market
  • Table 6 : Interim Economic Outlook Forecasts, by Country/Region, 2019-2021
  • Table 7 : Herbal Sleep Medicine
  • Table 8 : Number and Distribution of Persons Aged 60 and Over, by Region, 2019 and 2050
  • Table 9 : Recent Developments in Sleep Aids, 2021-2023
  • Table 10 : Global Market for Sleep Aids, by Product Type, Through 2027
  • Table 11 : Comparison of Selected Innerspring Mattresses
  • Table 12 : Comparison of Selected Memory Foam Mattresses
  • Table 13 : Comparison of Selected Air Mattresses
  • Table 14 : Global Market for Mattresses and Pillows as Sleep Aids, by Region, Through 2027
  • Table 15 : Global Market for Sleep Apnea Devices, by Region, Through 2027
  • Table 16 : Examples of Benzodiazepines
  • Table 17 : Pharmacokinetic Profiles of Common Benzodiazepines and their Approved Indications
  • Table 18 : Examples of New Sleeping Pills
  • Table 19 : Comparative Efficacies of Selected New Sleeping Pills
  • Table 20 : Global Market for Medication as Sleep Aids, by Region, Through 2027
  • Table 21 : Global Market for Sleep Laboratories, by Region, Through 2027
  • Table 22 : Home Sleep Tests vs. Facility-Based Testing
  • Table 23 : Global Market for Home Sleep Test Aids, by Region, Through 2027
  • Table 24 : Global Market for Sleep Aids, by Sleep Disorder, Through 2027
  • Table 25 : Mandatory Assessment of Chronic Insomnia
  • Table 26 : Physicians' Examinations for the Diagnosis of Chronic Insomnia
  • Table 27 : Drugs for Insomnia, by Type
  • Table 28 : Most Frequently Prescribed Insomnia Drugs
  • Table 29 : Global Market for Sleep Aids for Insomnia, by Region, Through 2027
  • Table 30 : Global Market for Sleep Aids for Sleep Apnea, by Region, Through 2027
  • Table 31 : Half-Life and Dosage Range of Drugs Used for Restless Leg Syndrome
  • Table 32 : Global Market for Sleep Aids for Restless Legs Syndrome, by Region, Through 2027
  • Table 33 : Prescription Drugs Used for Narcolepsy
  • Table 34 : Global Market for Sleep Aids for Other Sleep Disorders, by Region, Through 2027
  • Table 35 : Global Market for Sleep Aids, by Region, Through 2027
  • Table 36 : North American Market for Sleep Aids, by Product Type, Through 2027
  • Table 37 : North American Market for Sleep Aids, by Sleep Disorder, Through 2027
  • Table 38 : North American Market for Sleep Aids, by Country, Through 2027
  • Table 39 : European Market for Sleep Aids, by Product Type, Through 2027
  • Table 40 : European Market for Sleep Aids, by Sleep Disorder, Through 2027
  • Table 41 : European Market for Sleep Aids, by Country, Through 2027
  • Table 42 : Asia-Pacific Market for Sleep Aids, by Product Type, Through 2027
  • Table 43 : Asia-Pacific Market for Sleep Aids, by Sleep Disorder, Through 2027
  • Table 44 : Asia-Pacific Market for Sleep Aids, by Country, Through 2027
  • Table 45 : Latin American Market for Sleep Aids, by Product Type, Through 2027
  • Table 46 : Latin American Market for Sleep Aids, by Sleep Disorder, Through 2027
  • Table 47 : Middle Eastern and African Market for Sleep Aids, by Product Type, Through 2027
  • Table 48 : Middle Eastern and African Market for Sleep Aids, by Sleep Disorder, Through 2027
  • Table 49 : ActiGraph LLC: Product Portfolio
  • Table 50 : Advanced Brain Monitoring Inc.: Product Portfolio
  • Table 51 : Ambulatory Monitoring Inc.: Product Portfolio
  • Table 52 : Apnea Sciences: Product Portfolio
  • Table 53 : Apnea Sciences: Recent Developments, 2018 and 2019
  • Table 54 : Blairex Laboratories Inc.: Product Portfolio
  • Table 55 : Boehringer Ingelheim International GmbH: Product Portfolio
  • Table 56 : Braebon Medical Corp.: Product Portfolio
  • Table 57 : Cadwell Industries Inc.: Product Portfolio
  • Table 58 : CamNtech Ltd.: Product Portfolio
  • Table 59 : Circadiance: Product Portfolio
  • Table 60 : Cleveland Medical Devices Inc.: Product Portfolio
  • Table 61 : Drive DeVilbiss Healthcare: Product Portfolio
  • Table 62 : Fisher & Paykel Healthcare Ltd.: Product Portfolio
  • Table 63 : Glidewell: Product Portfolio
  • Table 64 : Hans Rudolph Inc.: Product Portfolio
  • Table 65 : Modern Dental Laboratory USA: Product Portfolio
  • Table 66 : Nihon Kohden Corp.: Product Portfolio
  • Table 67 : Pfizer Inc.: Products and Services
  • Table 68 : ResMed: Product Portfolio
  • Table 69 : Major Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market Shares of Sleep Aids, by Region, 2021
  • Figure 1 : Global Market Shares of Sleep Aids, by Product, 2021
  • Figure 2 : Global Market Shares of Mattresses and Pillows in Sleep Aids, by Region, 2021
  • Figure 3 : Global Market Shares of Sleep Apnea Devices, by Region, 2021
  • Figure 4 : Global Market Shares of Medication in Sleep Aids, by Region, 2021
  • Figure 5 : Global Market Shares of Sleep Laboratories, by Region, 2021
  • Figure 6 : Global Market Shares of Home Sleep Test Aids, by Region, 2021
  • Figure 7 : Global Market Shares of Sleep Aids, by Sleep Disorder, 2021
  • Figure 8 : Global Market Shares of Sleep Aids for Insomnia, by Region, 2021
  • Figure 9 : Global Market Shares of Sleep Aids for Sleep Apnea, by Region, 2021
  • Figure 10 : Global Market Shares of Sleep Aids for Restless Legs Syndrome, by Region, 2021
  • Figure 11 : Global Market Shares of Sleep Aids for Other Sleep Disorders, by Region, 2021
  • Figure 12 : Global Market Shares of Sleep Aids, by Region, 2021
  • Figure 13 : The U.S. Market for Sleep Aids, 2021-2027
  • Figure 14 : Canadian Market for Sleep Aids, 2021-2027
  • Figure 15 : German Market for Sleep Aids, 2021-2027
  • Figure 16 : U.K. Market for Sleep Aids, 2021-2027
  • Figure 17 : French Market for Sleep Aids, 2021-2027
  • Figure 18 : Italian Market for Sleep Aids, 2021-2027
  • Figure 19 : Spanish Market for Sleep Aids, 2021-2027
  • Figure 20 : Rest of the European Market for Sleep Aids, 2021-2027
  • Figure 21 : Chinese Market for Sleep Aids, 2021-2027
  • Figure 22 : Japanese Market for Sleep Aids, 2021-2027
  • Figure 23 : Indian Market for Sleep Aids, 2021-2027
  • Figure 24 : Australian Market for Sleep Aids, 2021-2027
  • Figure 25 : South Korean Market for Sleep Aids, 2021-2027
  • Figure 26 : Rest of Asia-Pacific Market for Sleep Aids, 2021-2027
  • Figure 27 : Boehringer Ingelheim International GmbH: Annual Revenue, 2019-2021
  • Figure 28 : Boehringer Ingelheim International GmbH: Revenue Share, by Business Segment, 2021
  • Figure 29 : Boehringer Ingelheim International GmbH: Revenue Share, by Region, 2021
  • Figure 30 : Fisher & Paykel Healthcare Ltd.: Annual Revenue, 2020-2022
  • Figure 31 : Fisher & Paykel Healthcare Ltd.: Revenue Share, by Product Group, 2022
  • Figure 32 : Fisher & Paykel Healthcare Ltd.: Revenue Share, by Region, 2022
  • Figure 33 : Pfizer Inc.: Annual Revenue, 2019-2021
  • Figure 34 : Pfizer Inc.: Revenue Share, by Business Segment, 2021
  • Figure 35 : Pfizer Inc.: Revenue Share, by Region, 2021
  • Figure 36 : ResMed: Annual Revenue, 2020-2022
  • Figure 37 : ResMed: Revenue Share, by Business Unit, 2022
  • Figure 38 : ResMed: Revenue Share, by Region, 2022